FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

40220711000001106: Seretide 50 Evohaler (CST Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 24-Nov 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2076641000001116 Seretide 50 Evohaler (CST Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2076651000001118 Seretide 50 Evohaler (CST Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Seretide 50 Evohaler (CST Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Is a Fluticasone 50micrograms/dose / Salmeterol 25micrograms/dose inhaler CFC free true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Is a Seretide Evohaler true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator CFC free true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has dispensed dose form Pressurised inhalation true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has specific active ingredient Salmeterol xinafoate true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salmeterol true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Seretide 50 Evohaler (CST Pharma Ltd) Has specific active ingredient Fluticasone propionate true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Seretide 50 Evohaler (CST Pharma Ltd) 120 dose Has AMP True Seretide 50 Evohaler (CST Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start